IP Library Granted Patent US 7,883,875
Granted Patent B2
US 7,883,875 · App. 11/093,427 · Granted Feb 8, 2011

Method or use of a solubilized glucan product to increase immunostimulation in animals

Assignee: Biotech Pharmacon ASA
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,883,875
App. No.
11/093,427
Granted
Feb 8, 2011
Kind
B2
Abstract

A method of increasing immunostimulation in animals by administering to the animal a glucan product comprising a branched β-(1,3) glucan with β-(1,3)-linked side chains being attached by a β-(1,6)-linkage and being essentially free of side chains containing more than four β-(1,6)-bound glucose units.

Claims (9)

1. A method of increasing immunostimulation in animals by administering to the animal a glucan product comprising a branched β-(1,3) glucan with β-(1,3)-linked side chains, said β-(1,3)-linked side chains comprising more than one β-(1,3)-linked glucose unit and being attached by a β-(1,6)-linkage wherein said glucan has been treated with a β-1,6-glucanase, and said product is essentially free of side chains of more than four β-(1,6)-bound glucose units and is greater than 5000 Daltons in weight.

2. The method according to claim 1 wherein the glucan is solubilized.

3. The method according to claim 1 wherein the glucan product is in a form selected from the group consisting of a food additive, animal feed, and pharmaceutical product.

4. The method according to claim 1 wherein the glucan is derived from yeast.

5. The method according to claim 4 wherein the yeast is of the family Saccharomyces.

6. The method according to claim 5 wherein the yeast is Saccharomyces cerevisiae.

7. The method according to claim 1 wherein the glucan product is in the form of a vaccine.

8. The method according to claim 7 wherein the vaccine is administered by intraperitoneal injection.

9. The method according to claim 1 wherein the animal is a fish.

Assignments (2)
CHANGE OF NAME Recorded Jan 20, 2010
From: BIOTEC ASA
To: BIOTEC PHARMACON ASA
Reel/Frame 023822/0186 →
CHANGE OF NAME Recorded Nov 12, 2009
From: BIOTEC-MACKZYMAL AS
To: BIOTEC ASA
Reel/Frame 023511/0268 →
Continuity (2)
Continuation 08716344 · Nov 26, 1996
Related Publication 20050255565A1 · Nov 17, 2005